Skip to main content
Gilbert White, MD, Oncology, Milwaukee, WI

GilbertC.WhiteMD

Oncology • Milwaukee, WI

Professor, Medicine, Medical College of Wisconsin

Join to view full profile

Are you Dr. White?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 40 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    9200 W Wisconsin Ave
    Division Of Neoplastic Diseases
    Milwaukee, WI 53226
    Phone+1 414-805-6800
    Fax+1 414-805-6805
  • Is this information wrong?

Summary

  • Dr. Gilbert White, MD is an oncologist in Milwaukee, Wisconsin. He is currently licensed to practice medicine in Wisconsin and North Carolina. He is a Professor at Medical College of Wisconsin.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1975 - 1976
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1973 - 1975
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1971 - 1973
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1971

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2022 - 2024
  • WI State Medical License
    WI State Medical License 2005 - 2021
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1986

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Wisconsin Researchers Awarded $5.3 Million for NIH Precision Medicine Research
    Wisconsin Researchers Awarded $5.3 Million for NIH Precision Medicine ResearchAugust 31st, 2017

Grant Support

  • Research Training In Transfusion MedicineNational Heart, Lung, And Blood Institute2010–2011
  • Blood Dyscrasias And Transfusion MedicineNational Heart, Lung, And Blood Institute2010
  • Initiative In Stem Cell BiologyNational Center For Research Resources2010
  • Role Of Carboxyterminal Hypervariable Region In Rap1b FunctionNational Heart, Lung, And Blood Institute2009–2010
  • The Role Of RAP1 In Integrin Activation And Platelet SignalingNational Heart, Lung, And Blood Institute2006–2007
  • Administrative CoreNational Heart, Lung, And Blood Institute2006
  • Extension Study To Characterize Bddrfviii Manufactured By Refacto AFNational Center For Research Resources2005
  • Role Of Rap1b In Integrin Activation And Platelet SignalingNational Heart, Lung, And Blood Institute2004–2005
  • Core A-- Adminsitrative CoreNational Heart, Lung, And Blood Institute2004
  • Transfusion Medicine/Hemostasis Clinical Research Netwo*National Heart, Lung, And Blood Institute2002–2003
  • Structure And Function Of Vascular IntegrinsNational Heart, Lung, And Blood Institute1993–2003
  • Recombinant Factor VIII SQ In Previously Treated Hemophilia ANational Center For Research Resources1999–2002
  • R97 022: Intron A + Ribavirin For Hepatitis C &Inherited Coagulation DiseaseNational Center For Research Resources1999–2002
  • Antihemophilic Factor (Af Rahf) In Prev Treated Severe Hemophilia ANational Center For Research Resources1999–2002
  • Structure And Function Of The Beta Cytoplasmic DomainsNational Heart, Lung, And Blood Institute1998–2002
  • Structure/Function Of Vascular IntegrinsNational Heart, Lung, And Blood Institute1997–2002
  • Predictors Of Inhibitors In Hemophilia ANational Center For Research Resources2000
  • Factor VIII Vector For Treatment Of Severe Hemophilia ANational Center For Research Resources2000
  • Antiretriviral Therapy &Indinavir Sulfate In HIV-1 HemophiliaNational Center For Research Resources2000
  • Platelet Specific Knockout Of Signaling ProteinsNational Heart, Lung, And Blood Institute1997–2000
  • Comparing Recombinant Factor VIII VS Hemofil(R)-M In HemophiliaNational Center For Research Resources1997–1999
  • Three Segment Phase I/II Study In Previously Treated Hemophilia BNational Center For Research Resources1996–1999
  • Internatl Symposium On Gene Therapy For HemophiliaNational Heart, Lung, And Blood Institute1997
  • Study Of R-Viii SQ In Hemophilia A Patients During SurgeryNational Center For Research Resources1997
  • Recombinant Human Factor IX In Previously Treated Patients With Hemophilia BNational Center For Research Resources1997
  • Recombinant Factor VIII In The Treatment Of Previously Treated Hemophilia A PTSNational Center For Research Resources1997
  • Ligand Binding Domains Of Vascular IntegrinsNational Heart, Lung, And Blood Institute1995–1997
  • Recombinant Factor VIII In Treatment Of Previously Treated Hemophilia A PatientsNational Center For Research Resources1995–1997
  • Genetics Institute Protocol C9417-21--Recombinant Human Factor IXNational Center For Research Resources1996
  • Effect Of Bleeding Time And Calculation Of Von Willebrand FactorNational Center For Research Resources1995
  • Molecular Biology Of Cytoadhesins--Oral Tissue ModelNational Institute Of Dental &Craniofacial Research1987–1990

Dr. Gilbert White, Dr. Gilbert White, MD, Dr. G White, Dr. Gilbert C. White